For: | Dahiya DS, Kumar G, Parsa S, Gangwani MK, Ali H, Sohail AH, Alsakarneh S, Hayat U, Malik S, Shah YR, Pinnam BSM, Singh S, Mohamed I, Rao A, Chandan S, Al-Haddad M. Remimazolam for sedation in gastrointestinal endoscopy: A comprehensive review. World J Gastrointest Endosc 2024; 16(7): 385-395 [PMID: 39072252 DOI: 10.4253/wjge.v16.i7.385] |
---|---|
URL: | https://www.wjgnet.com/1948-5190/full/v16/i7/385.htm |
Number | Citing Articles |
1 |
Ha-Jung Kim, Yeon Ju Kim, Jungmin Lee, Daun Jeong, Young Ho Shin, Young-Jin Ro, Hyungtae Kim, Won Uk Koh. Comparison of the recovery profiles of propofol, dexmedetomidine, and remimazolam for intraoperative sedation in patients undergoing upper limb surgery under brachial plexus blockade: a randomized controlled trial. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 2025; doi: 10.1007/s12630-025-02987-3
|
2 |
Bo Zhou, Jian Liu, Lu Jin, Xiaoling Huang. Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1/3 signaling. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03820-3
|